Creating the 365 Day Long
Conference and Expo
March 10, 2014
3:15 PM– 4:30 PM
Hashtag: #ideas14 LE3
Barbara A. Myers, CAE, Vice President, Association
Services, IMN Solutions
Kevin Miller, President, Frost Miller Group
Learner Outcomes
• To learn benefits of a
year round event model.
• To develop a strategy for
transitioning an
event/exhibition to a year
round experience.
• To gain and share ideas
for specific tactics that
can be implemented.
What is a 365 Day Experience?
• IAEE Future Trends Task Force – White Paper: Future Trends Impacting the Exhibition and Events Industry.
• Transitioning ―episodic‖ events to year-round communities around specific content
• Implementing a digital media platform with the right mix of technology, skilled personnel, consultants, vendors and ―content‖ strategy.
• Enables the show organizer, attendees, exhibitors, sponsors, presenters and prospects to engage before, during and after a live event (including, education, operations, promotion, sales, content, data, social media, face-to-face)
Benefits
• Counters impact of digital media’s 24/7 competitive interaction with fixed date F2F events
• Increases engagement (among all event stakeholders which value/ROI)
• Expands reach and generates impressions outside existing databases, lists, etc.
• Financial (revenue generation/cost containment)
• Addresses generation challenges and reaches ―online generation‖
―The Next On-line Generation‖
How Tweens are
Communicating!
By the Numbers…
Strategy and Planning
Strategic Planning Goals Audience
Assessment Marketing
Execution Engagement
Tactics
Strategy
• Identify events to transition from ―episodic‖ to year-round
communities aligned with strategic priorities and growth goals of
the association
• Evaluate current digital media strategy and use
• Answer question - ―What kind of value should I be creating for my
audience year-round that makes the event the natural next step in
their buying process?‖
Goals
• Engagement
• Mission Fulfillment
• Revenue
Audience Assessment
Non-
Attendees
Exhibitor/Sponsors Members Speakers
Press/Bloggers
Marketing
• Clearly Defined Plan
• Describe Target Audience
• Tactics Align with Audience
• Maximize Registration Opportunities
• Use Social Media to Recruit, Engage, and
Retain Audiences
• Seek Ongoing, Persistent Relationships with
Audience
Content in Action
Friday,(September(13,(2013(10:56:08(AM(Eastern(Daylight(Time
Page(1(of(3
Subject: Before&FMG&Don't&Miss&ISPE's&Upcoming&Events
Date: Wednesday,&September&11,&2013&7:47:08&AM&Eastern&Daylight&Time
From: Renee&Smith
To: Barbara&Myers
CC: Danielle&Hould
Here’s&the&combined&email.Renee&
From: ISPE [mailto:[email protected]]
Sent: Wednesday, September 11, 2013 7:46 AM
To: Renee Smith
Subject: ** iMIS Email Marketing Test ** Don't Miss ISPE's Upcoming Events
Send to a friend | Mobile Version
While ISPE finalizes programming for upcoming educational events, be sure to visit our conferencewebsites for the latest updates on speakers, agendas and session details.
The State of QbD in the BioPharmaceutical Industry:Criticality Assessment, Design Space Implementation andControl10 - 11 April 2013 • San Francisco, California USA
Can your company afford the cost of production withoutQbD? Quality by Design can significantly alter the risk landscapeand produce significant business benefits. This groundbreaking event offers you in-depth case studies,lessons learned and best practices in implementing QbD.Explore challenges and solutions with experts and peers inworkshops on design space, control strategies, successfuldossiers and lifecycle management.
Who is attending? Leaders from Abbott, Amgen, Eli Lilly,
Page(2(of(3
Genentech, MedImmune, Merck, Pfizer and more!
Early bird registration ends 12 March 2013.
Add this conference to your calendar
Redefining the "C" in CGMP: Ensuring a Reliable Supply ofQuality Medicines11 - 13 June 2013 • Baltimore, Maryland USA
ISPE and FDA collaborate to provide content focused oncreating and maintaining a quality culture. Special events includeBreakfast with the Inspectors, Meet the Press and Hot TopicDiscussion Forum.
Delegates will also have the unique opportunity to be among thefirst to hear results of ISPE’s Drug Shortage Survey, which willbe announced at the conference.
Early bird registration ends 13 May 2013.
Add this conference to your calendar
Biotechnology 2013: Looking Ahead to the 4th Decade27 - 28 August 2013 • Durham, North Carolina USA
As the modern Biotechnology Industry moves into its fourthdecade, the dynamics of the industry are changing on manydifferent fronts. This 2-day educational intensive will providefocused content on:
Biopharmaceutical manufacturing and process
development
Facility design and integration
Compliance and process validation
Early bird registration ends 30 July 2013.
Add this conference to your calendar
14% Open Rate
23% Open Rate
Friday,(September(13,(2013(11:10:27(AM(Eastern(Daylight(Time
Page(1(of(2
Subject: Gamification*Email-*Learn*How*the*A-VAX*Case*Study*Can*Help*You
Date: Wednesday,*September*11,*2013*7:44:59*AM*Eastern*Daylight*Time
From: Renee*Smith
To: Barbara*Myers
I*can’t*get*a*full*screen*shot*of*this*so*here*is*the*full*email.*Combined*on*its*way.Renee*
From: ISPE [mailto:[email protected]]
Sent: Wednesday, September 11, 2013 7:44 AM
To: Renee Smith
Subject: ** iMIS Email Marketing Test ** Learn How the A-VAX Case Study Can Help You
If this email does not display properly, click here to view the mobile version.
What You Need to Know
about the A-VAX Case Study
Register today to learn practical applications
directly from study participants
Register Today >>
Understand and take away practical applications from the
A-VAX Case Study at Biotechnology, a 2-day Symposium
27 – 28 August 2013 in Durham, NC.
Sam Venugopal, Director, PricewaterhouseCoopers and
Bradley Kosiba, PhD, CPIP, Principal, BK Collaborative
LLC will lead this important workshop where delegates will
Biotechnology is
brought to you by
ISPE and the Biotech
CoP in cooperation
with your local CaSA
Chapter!
Page(2(of(2
Explore the content and application of the A-VAXCase Study.
Understand how QbD can be applied to vaccinedevelopment and benefit the manufacturinglifecycle.
Identify the specific challenges involved in QbDand ways they can be overcome in the vaccineenvironment.
Gain insight into the challenges regulators face asthey better define their expectations related to QbD.
Speakers from companies involved will participate
Michael Washabaugh, PhD, Senior Director,
MedImmune
Paul Rohlfing, Senior Director Global CMC, Pfizer, Inc.
Michael Schwartz, Associate Director Global Regulatory
Affairs, GlaxoSmithKline-Vaccines
Michael Kosinski, Senior Principle Scientist, Merck &
Co, Inc.
Take a quick, 3-question quiz about the A-VAXTake a quick, 3-question quiz about the A-VAX
Case Study for a chance to win a Case Study for a chance to win a complimentarycomplimentary
registration to this conferenceregistration to this conference.*.*
Learn more at: www.ISPE.org/2013BiotechConference
*Registration includes conference fee only valued at ($1745-2,014). Winner is
responsible for lodging and travel expenses. Contest only applicable to new
registrants. Winner will be announced and contacted on 12 August 2013
© 2013 ISPE 60% Open Rate
Execution
• Evaluate internal/external resources
• Buy-in from organizational stakeholders
• Roles and responsibilities
• Strategy/goals, goal oriented tactical plan and time lines
• Budget
• Training
• Evaluate against goals
Engagement Tactics Communication
• Digital content and media: streaming and downloads
• SEM advertising: banner and text
• Microsites and similar event-branded websites – content hub!
• Content sharing: Slideshare, iTunesU, YouTube
• Email: both email marketing and updates/advisory
• Twitter (or similar) as back channel during presentation
Participation
• Online/mobile gaming and sweepstakes
• Mobile-specific applications such as attendee networking/notification
• ―Virtual/Hybrid‖ events and content distribution (―remote‖ education, networking, etc.)
• Physical interactive touchscreens, interactive environments
• Augmented/reality,enhanced reality
• Tablet-guided discussion — animations, imagery, diagrams
• NFC, RFID — lead capture, measurement
• Gamification
• QR Codes — more info, check-in’s credential exchange
Propagation
• Blogs and similar one-to-many publishing platforms
• -Twitter, Facebook, association propriety social networks and other one-to-one engagement platforms
• #Hashtags
• RSS and other content syndication
Questions?
Contact Us
Barbara A. Myers, CAE
Vice President, Association Services
IMN Solutions
Kevin Miller
President
Frost Miller Group